Acadia Healthcare Q3 Earnings Call Highlights

Acadia Healthcare (ACHC) reported Q3 revenue guidance of $3.44B-$3.46B, adjusted EBITDA of $615M-$625M, and adjusted EPS of $1.70-$1.80. The company lowered its full-year capital expenditure forecast to $210M-$230M. It added 220 licensed beds in Q3, with plans for further facility expansions. Medicaid work requirements and legal expenses were discussed, with minimal expected impact. ACHC operates behavioral healthcare facilities in the U.S. and U.K.

Original reporting
Published Nov 5, 2026, 4:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 4:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Acadia Healthcare Q3 Earnings Call Highlights — source image
Decision brief

The 30-second read

$ACHCBearishMed
01

Why it matters

The earnings release provides fresh guidance and cash‑flow metrics that were not previously public.

02

Market read

First‑report earnings and guidance for Q3, affecting valuation and sector sentiment.

03

What to watch

Potential incremental EBITDA from Florida and Ohio programs could offset guidance cuts if approved.

Relevance 8/10Novelty 8/10Timing: after market close

Background

Acadia Healthcare (NASDAQ:ACHC) provides psychiatric and addiction treatment services across the U.S. and the U.K.

Company-level read

Ticker impact

$ACHCBearishHigh confidence
Context

Q3 earnings released with revenue $3.44‑$3.46B, adjusted EBITDA $615‑$625M and lowered full‑year capex guidance.

Expected impact

likely downside as market prices in lower capex outlook

Evidence & confidence

Earnings are in line but capex reduction signals slower growth, prompting investors to trim positions.

Market effects

Behavioral health sector may see modest pressure as Acadia signals slower expansion.

U.S. healthcare investors may adjust exposure to specialty providers.

Limited; primarily affects U.S. listed behavioral health stocks.

Counterpoint

Capex cut could improve cash flow and reduce leverage, offering a buying opportunity if the market overreacts.

Key entities

  • Acadia Healthcare

    Provider of behavioral health services.

  • David Duckworth

    CEO who discussed guidance and capex.

Related articles

HighAI 8/10

5 revealing analyst questions from Acadia Healthcare’s Q3 2026 earnings call

Acadia Healthcare reported Q3 2026 revenue of $895.3M, beating estimates by 2%, and raised full-year guidance. Adjusted EPS of $0.60 beat estimates by 29.2%, with full-year guidance increased by 14.8%. Analysts discussed growth opportunities, capital expenditures, and Medicaid impacts during the earnings call. According to the company, operational discipline and cost controls are key for future improvement.

$ACHCHighAI 8/10

Acadia Healthcare (ACHC) Q3 2026 Earnings Call Transcript

Acadia Healthcare (ACHC) reported Q3 2026 revenue of $895.3M, up 5.1% YoY, driven by patient volume growth and higher revenue per patient day. Adjusted EBITDA rose 2% to $176.4M, while adjusted EPS fell to $0.60 from $0.72. The company raised full-year revenue and EBITDA guidance, citing strong demand for behavioral health services. Management noted challenges from NY Medicaid changes and a tight labor market.

$ACHCHigh

Acadia Healthcare: Q3 Earnings Snapshot

Acadia Healthcare (ACHC) reported Q3 earnings of $34.5M, or 38 cents per share, beating estimates of 46 cents. Revenue was $895.3M, exceeding forecasts of $869.3M. The company expects full-year earnings of $1.70-$1.80 per share and revenue of $3.44B-$3.46B. Shares have risen 56% in the past year.